Erratum: Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169)

M. M. Morrison, M. M. Williams, D. B. Vaught, D. Hicks, J. Lim, C. McKernan, L. Aurisicchio, G. Ciliberto, C. Simion, C. Sweeney, R. S. Cook

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1206
Number of pages1
JournalOncogene
Volume35
Issue number9
DOIs
StatePublished - Mar 3 2016

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Morrison, M. M., Williams, M. M., Vaught, D. B., Hicks, D., Lim, J., McKernan, C., Aurisicchio, L., Ciliberto, G., Simion, C., Sweeney, C., & Cook, R. S. (2016). Erratum: Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth (Oncogene (2016) 35 (1143-1152) DOI:10.1038/onc.2015.169). Oncogene, 35(9), 1206. https://doi.org/10.1038/onc.2015.418